© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
Politics and Policy
How Will Real-World Evidence Help Drive Solutions for COVID-19?
July 19, 2020
How real-world evidence will help FDA develop a vaccine.
Word From FDA, NIH on COVID-19 Vaccine: No Cutting Corners
July 05, 2020
FDA outlines what it will take to get a COVID-19 vaccine approved, while NIH offers its research strategy.
Stark, Anti-Kickback Statute Reform: 5 Things Healthcare Execs Need to Know
October 17, 2019
In a long-awaited move, HHS proposes to overhaul the federal anti-kickback statute and Stark Law for today’s value-based environment.
Do Certificate-of-Need Laws Still Make Sense in 2019?
September 03, 2019
They were formed to provide greater access to healthcare and lower costs, but they may be doing more harm than good.
Nine Reasons Health Execs Are Excited for the Future
August 26, 2019
From new models to AI, the things that get health execs excited about the future of healthcare.
Price Transparency Rule Could Pose Challenges
August 09, 2019
Two challenges providers may face under the proposed rule.
What Trump’s Kidney Executive Order Means for Healthcare
July 28, 2019
How the president’s Advancing American Kidney Health’ Initiative will impact policy.
New York Not-For-Profit Nursing Home Sales are Subject to Increased Scrutiny by the Attorney General
July 26, 2019
Due, at least in part, to the substantial increase in the number of sales of New York not-for-profit skilled nursing facilities to for-profit operators since 2015, the Charities Bureau of the New York State Attorney General is subjecting such transactions to increased scrutiny, including objecting to certain of such sales, increasing the time and cost associated with such transactions.
Seven Pharmacy Regulations Health Execs Must Watch
June 13, 2019
These are the important policies to watch out for in 2019.
The Future of Stark Law
June 03, 2019
In the three decades since its passage, Stark Law has become one of the most significant sources of regulatory burden on physicians and, ultimately, for Medicare beneficiaries.